Mark Hollywood
Hoofd Techniek/Wetenschap/O&O bij ZYMEWORKS INC.
Actieve functies van Mark Hollywood
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZYMEWORKS INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Hoofd Techniek/Wetenschap/O&O | 30-04-2019 | - |
Loopbaan van Mark Hollywood
Eerdere bekende functies van Mark Hollywood
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2010 | 01-01-2019 |
| CELLCYTE GENETICS CORPORATION | Corporate Officer/Principal | - | - |
Opleiding van Mark Hollywood
| Western Illinois University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ZYMEWORKS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CellCyte Genetics Corp.
 CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services CellCyte Genetics Corp. engaged in the discovery and development of stem cell therapeutic products. It enabled therapeutic advancements to safely deliver stem cells through the patient's own circulatory or vascular system directly into a specific diseased, damaged or dying organ. The company was founded on March 9, 2004 and was headquartered in Freeland, WA. | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Mark Hollywood
- Ervaring